To Evaluate the Efficiency and Results of Adding BFR to the Physical Therapy Program fo Managing Adolescents Presented With Spasmotic Flatfoot Deformities Compared to the Standard Physical Therapy Program Without BFR
Condition(s) studied
Investigational drug(s) / intervention(s)
blood flow restriction: The addition of BFR to low-load dynamic exercise training is effective for augmenting changes in both muscle strength and size.
Study summary
The goal of this randomized clinical trial is to evaluate the efficiency and results of adding blood flow restriction (BFR) training to the physical therapy program for managing adolescents presented with spasmotic flatfoot deformities compared to the Standard physical therapy program without blood flow restriction.
Eligibility
Primary outcome measure(s)
- American Orthopedic Foot and Ankle score (AOFAS) — baseline and 2 months
Ankle-Hindfoot Scale: a standard method of reporting the clinical and functional status of the ankle and foot. The systems incorporate both subjective and objective factors into numerical scales to describe function, alignment, and pain. A score of 100 points is possible in a patient with no pain, full range of sagittal and hindfoot motion, no ankle or hindfoot instability, good alignment, ability to walk more than six blocks, ability to ambulate on any walking surface, no discernible limp, no limitation of daily or recreational activities, and no assistive devices needed for ambulation. Fifty points were assigned to function, 40 to pain, and 10 to alignment. - Range of motion (ROM) — baseline and at last follow up, 2 months
Ankle range of motion of the sagittal plane (dorsiflexion and plantar flexion) and in the coronal plane (inversion and eversion), using a goniometer.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Assiut University Hospital, Physical Therapy Unit | Asyut | Egypt | Recruiting |
More Assiut University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07343752 on ClinicalTrials.gov ↗ ← All trials in Egypt